UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2013, Volume 310, Issue 23, pp. 2533 - 2543
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | General aspects | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Urine | Heart Failure - complications | Acute Disease | Glomerular Filtration Rate | Double-Blind Method | Cystatin C - blood | Humans | Middle Aged | Kidney Diseases - drug therapy | Male | Treatment Outcome | Dopamine - administration & dosage | Natriuretic Peptide, Brain - administration & dosage | Heart Failure - drug therapy | Natriuretic Agents - administration & dosage | Aged, 80 and over | Diuretics - therapeutic use | Female | Aged | Kidney Diseases - complications | Drug Therapy, Combination | Vasodilator Agents - administration & dosage | Kidney - physiopathology | Heart failure | Dopamine | Diuretics | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Neurotransmitters | Nephrology | Kidney diseases | Drug dosages | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 12, pp. 1123 - 1133
acute | heart failure | registry | hospitalization | inpatient | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Age Distribution | Vasodilator Agents - therapeutic use | Anemia - epidemiology | United States | Humans | Catheterization, Swan-Ganz - utilization | Male | Dyspnea - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Electrocardiography | Female | Registries | Coronary Angiography - utilization | Heart Failure - diagnosis | Heart Failure - epidemiology | Heart Failure - etiology | Drug Utilization - statistics & numerical data | Length of Stay - statistics & numerical data | Adrenergic beta-Antagonists - therapeutic use | Hyponatremia - epidemiology | Cardiac Resynchronization Therapy - utilization | Echocardiography | Glomerular Filtration Rate | Hospital Mortality | Comorbidity | Europe | Defibrillators, Implantable - utilization | Hospitalization | Evidence-Based Medicine | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Quality Improvement | Asia | Natriuretic Peptides - analysis | Sex Distribution | Diuretics - therapeutic use | Aged | Angiotensin Receptor Antagonists - therapeutic use | Heart failure | Medical colleges | Medical research | Mortality | Therapeutics | Economic aspects | Medicine, Experimental | Natriuretic peptides | Homeopathy | Materia medica and therapeutics | Index Medicus | Abridged Index Medicus
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 02/2017, Volume 69, Issue 2, pp. 267 - 274
arterial stiffness | heart failure | ejection fraction | pulse wave velocity | hypertension | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Body Composition | United States - epidemiology | Prognosis | Prospective Studies | Follow-Up Studies | Pulse Wave Analysis | Humans | Risk Factors | Heart Failure - physiopathology | Proportional Hazards Models | Stroke Volume - physiology | Male | Forecasting | Incidence | Vascular Stiffness - physiology | Aging | Female | Aged | Heart Failure - diagnosis | Health Status | Heart Failure - epidemiology | Index Medicus | Heart failure | Hypertension | Pulse wave velocity | Arterial stiffness | Ejection fraction
Journal Article
European journal of heart failure, ISSN 1388-9842, 06/2020, Volume 22, Issue 6, pp. 941 - 956
Heart failure | Coronavirus | Management | Diagnosis | COVID‐19 | SARS‐CoV‐2 | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Pandemics | Comorbidity | Pneumonia, Viral - therapy | Europe | Humans | COVID-19 | Heart Failure - therapy | SARS-CoV-2 | Societies, Medical | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | China | Coronavirus Infections - therapy | Betacoronavirus | Disease Management | Cardiology | Heart Failure - epidemiology | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2010, Volume 55, Issue 17, pp. 1803 - 1810
heart failure | cardiac resynchronization | HF device diagnostics | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Heart Failure - therapy | Algorithms | Prospective Studies | Defibrillators, Implantable | Humans | Heart Failure - physiopathology | Female | Male | Aged | Heart Failure - diagnosis | Hospitalization | Lung - physiopathology | Heart rate | Heart failure | Cardiac arrhythmia | Heart attacks | Mortality | Committees | Chronic obstructive pulmonary disease | Trends | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2013, Volume 309, Issue 11, pp. 1 - 11
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Epidemiology | Ventricular Dysfunction, Left | Double-Blind Method | Follow-Up Studies | Patient Readmission | Fumarates - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Amides - therapeutic use | Antihypertensive Agents - therapeutic use | Heart Failure - drug therapy | Stroke Volume | Renin - antagonists & inhibitors | Female | Aged | Heart Failure - mortality | Heart failure | Hospitalization | Inhibitor drugs | Drug therapy | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
JACC. Heart failure, ISSN 2213-1779, 02/2013, Volume 1, Issue 1, pp. 1 - 20
cardiovascular disease | heart failure | calcium cycling | left ventricular assist device | biomarkers | review | Calcium cycling | Heart failure | Left ventricular assist device | Biomarkers | Cardiovascular disease | Review | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Biomarkers - metabolism | Myocarditis - etiology | Humans | Middle Aged | Heart Failure - physiopathology | Male | Ventricular Remodeling - physiology | Hemodynamics - physiology | Forecasting | Myocarditis - diagnosis | Cardiotonic Agents - therapeutic use | Young Adult | Heart Failure - therapy | Calcium Channels - physiology | Stem Cell Transplantation - methods | Models, Biological | Myocytes, Cardiac - physiology | Aged, 80 and over | Adult | Female | Aged | Heart Failure - etiology | Heart-Assist Devices | Genetic Therapy - methods
Journal Article